Journal Article Summary
The article investigates the performance and manufacturability of a new oral dosage form called Liqui-Pellet, specifically focusing on the effects of the ratio of carrier (Avicel PH101) and coating material (Aerosil 300) on its drug release rate. This topic is significant because Liqui-Pellet technology aims to improve the bioavailability of poorly water-soluble drugs, which is a common challenge in the pharmaceutical industry. By enhancing drug dissolution rates, Liqui-Pellet formulations could potentially reduce the required dosage and improve patient outcomes, making this research relevant for future drug development.
The study involved preparing various Liqui-Pellet formulations with different ratios of the carrier and coating materials, and assessing their physicochemical properties, including particle size, flowability, and drug release profiles. The findings revealed that while the ratio of carrier to coating material did not significantly impact the overall success of Liqui-Pellet production, it did influence the size of the pellets and slightly affected the drug release rate. Specifically, decreasing the concentration of Avicel PH101 while increasing Aerosil 300 led to smaller pellet sizes and a modest increase in drug release rate after two hours.
Despite the promising results, the study has limitations, including the small number of formulations that successfully produced Liqui-Pellets and the challenges faced during the spheronization process. Patients and caregivers should be aware that while Liqui-Pellet technology shows potential, it is still in the experimental stage, and further research is needed to optimize formulations. It is advisable for readers to discuss any questions or concerns about new drug delivery systems with their healthcare professionals to ensure safe and effective treatment options.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.
Article Cited
- Lam Matthew, Nokhodchi Ali. Factors affecting performance and manufacturability of naproxen Liqui-Pellet. DARU Journal of Pharmaceutical Sciences 2020. DOI: 10.1007/s40199-020-00362-9. PMID: 32757155. PMCID: PMC7704869.
Featured Pill Pals Product
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
